Carolina Uribe-Cruz

Prof. Dr. Carolina Uribe-Cruz

PPG: gastroenterologia, UNIVERSIDADE FEDERA RIO GRANDE DO SUL, Porto Alegre, Rio Grande do Sul, Brazil
orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 September 2017 in Neurotoxicity Research
Verified
Journal Article
Closed access
PDF file
JAJotele Fontana Agostini
Jotele Fontana Agostini
HTHelena Cristina Zuehl Dal Toé
Helena Cristina Zuehl Dal Toé
KVKarine Medeiros Vieira
Karine Medeiros Vieira
SBSamira Leila Baldin
Samira Leila Baldin
NCNaithan Ludian Fernandes Costa
Naithan Ludian Fernandes Costa
EREduardo Pacheco Rico
Eduardo Pacheco Rico

3 June 2014 in Inflammation Research
Verified
Journal Article
Closed access
PDF file
LPLeonardo Pedrazza
Leonardo Pedrazza
ALAdroaldo Lunardelli
Adroaldo Lunardelli
CLCarolina Luft
Carolina Luft
CUCarolina Uribe-Cruz
Carolina Uribe-Cruz
FMFernanda Cristina de Mesquita
Fernanda Cristina de Mesquita
JOJarbas Rodrigues de Oliveira
Jarbas Rodrigues de Oliveira

1 September 2020 in Clinical and Experimental Gastroenterology
Verified
Journal Article
Open access
PDF file
LLLarisse Longo
Larisse Longo
JFJéssica Tonin Ferrari
Jéssica Tonin Ferrari
Pabulo Henrique RampelottoPabulo Henrique Rampelotto
Pabulo Henrique Rampelotto
GDGustavo Hirata Dellavia
Gustavo Hirata Dellavia
APAmanda Pasqualotto
Amanda Pasqualotto
MAMario Reis Alvares-da-Silva
Mario Reis Alvares-da-Silva
Background/Aim: The interactions between the gut and liver have been described in the progression of non-alcoholic steatohepatitis (NASH). The aim of this study was to develop an experimental nutritional model of NASH simulating metabolic changes occurring in humans. Materials and Methods: Adult male Sprague Dawley rats were randomized into two groups: controls (standard diet) and intervention (high-fat and choline-deficient diet) for 16 weeks, each experimental group with 10 animals. Biochemical analysis, hepatic lipid content, microRNAs, inflammatory, gut permeability markers and gut microbiota were measured. Results: Animals in the intervention group showed significantly higher delta Lee index (p=0.017), abdominal circumference (p< 0.001), abdominal adipose tissue (p< 0.001) and fresh liver weight (p< 0.001), as well as higher serum levels of alanine aminotransferase (p=0.010), glucose (p=0.013), total cholesterol (p=0.033), LDL cholesterol (p=0.011), and triglycerides (p=0.011), and lower HDL cholesterol (p=0.006) compared to the control group. Higher TLR4 (p=0.041), TLR9 (p=0.033), MyD88 (p=0.001), Casp1 (p< 0.001), NLPR3 (p=0.019), liver inflammation index interleukin (IL)-1β/IL10 (p< 0.001), IL6/IL10 (p=0.002) and TNFα/IL10 (p=0.001) were observed in the intervention group, and also lower permeability markers Ocln (p=0.003) and F11r (p=0.041). Gene expression of miR-122 increased (p=0.041) and miR-145 (p=0.010) decreased in the intervention group. Liver steatosis, inflammation and fibrosis, along with collagen fiber deposition increment (p< 0.001), were seen in the intervention group. Regarding gut microbiota, Bray-Curtis dissimilarity index and number of operational taxonomic units were significantly different (p< 0.001) between the groups. Composition of the gut microbiota showed a significant correlation with histopathological score of NAFLD (r=0.694) and index IL-1β/IL-10 (r=0.522). Conclusion: This experimental model mimicking human NASH demonstrated gut and liver interaction, with gut microbiota and intestinal permeability changes occurring in parallel with systemic and liver inflammation, miRNAs regulation and liver tissue damage.

1 January 2017 in World Journal of Hepatology
Verified
Journal Article
Open access
ASAna Claudia Reis Schneider
Ana Claudia Reis Schneider
CGCleandra Gregório
Cleandra Gregório
CUCarolina Uribe-Cruz
Carolina Uribe-Cruz
RGRanieli Guizzo
Ranieli Guizzo
TMTaís Malysz
Taís Malysz
TSThemis Reverbel da Silveira
Themis Reverbel da Silveira
To evaluate the effects of chronic exposure to ethanol in the liver and the expression of inflammatory genes in zebrafish. Zebrafish (n = 104), wild type, adult, male and female, were divided into two groups: Control and ethanol (0.05 v/v). The ethanol was directly added into water; tanks water were changed every two days and the ethanol replaced. The animals were fed twice a day with fish food until satiety. After two and four weeks of trial, livers were dissected, histological analysis (hematoxilin-eosin and Oil Red staining) and gene expression assessment of adiponectin, adiponectin receptor 2 (adipor2), sirtuin-1 (sirt-1), tumor necrosis factor-alpha (tnf-a), interleukin-1b (il-1b) and interleukin-10 (il-10) were performed. Ultrastructural evaluations were conducted at fourth week. Exposing zebrafish to 0.5% ethanol developed intense liver steatosis after four weeks, as demonstrated by oil red staining. In ethanol-treated animals, the main ultrastructural changes were related to cytoplasmic lipid particles and droplets, increased number of rough endoplasmic reticulum cisterns and glycogen particles. Between two and four weeks, hepatic mRNA expression of il-1b, sirt-1 and adipor2 were upregulated, indicating that ethanol triggered signaling molecules which are key elements in both hepatic inflammatory and protective responses. Adiponectin was not detected in the liver of animals exposed and not exposed to ethanol, and il-10 did not show significant difference. Data suggest that inflammatory signaling and ultrastructural alterations play a significant role during hepatic steatosis in zebrafish chronically exposed to ethanol.

26 June 2019 in Journal of the American College of Nutrition
Verified
Journal Article
Closed access
JBJuliana Paula Bruch-Bertani
Juliana Paula Bruch-Bertani
CUCarolina Uribe-Cruz
Carolina Uribe-Cruz
APAmanda Pasqualotto
Amanda Pasqualotto
LLLarisse Longo
Larisse Longo
RARaquel Ayres
Raquel Ayres
VDValesca Dall'Alba
Valesca Dall'Alba
Objective: Alcoholic liver disease (ALD) is among the leading causes of death from liver disease. Among the factors involved in its pathogenesis are inflammation and increased intestinal permeability. The aim of this study was to assess the effect of Lactobacillus rhamnosus GG (LGG) on hepatic lipid accumulation, activation of inflammasomes, and gut permeability markers in experimental model of ALD with zebrafish. Methods: An experiment was conducted to assess the effective LGG dose capable of promoting intestinal colonization. Animals were divided into three groups (n = 64/group): ethanol group (E), ethanol + probiotic group (EP), and control group (C). Groups E and EP were exposed to 0.5% ethanol concentration for 28 days. At the end of this period, animals were euthanized, and livers were collected for Oil Red staining and assessment of the inflammasome system. Intestines were collected for evaluation of gut permeability markers. Results: The dose of 1.55 × 106 UFC LGG/fish/d promoted intestinal colonization. Group EP presented lower hepatic lipid accumulation, lower il-1β expression, and higher cldn15a expression when compared to group E. Conclusions: Supplementation with LGG was protective for hepatic steatosis in ALD model. In addition, LGG influenced the modulation of the inflammatory response and markers of gut permeability, improving the gut barrier structure.

11 September 2013 in Liver International
Verified
Journal Article
Closed access
PDF file
MLMónica L. López
Mónica L. López
CKCarlos O. Kieling
Carlos O. Kieling
CUCarolina Uribe-Cruz
Carolina Uribe-Cruz
AOAlessandro Osvaldt
Alessandro Osvaldt
GMGustavo Ochs de Muñoz
Gustavo Ochs de Muñoz
UMUrsula Matte
Ursula Matte